Does ZOLADEX Cause Malignant neoplasm progression? 28 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Malignant neoplasm progression have been filed in association with ZOLADEX. This represents 18.3% of all adverse event reports for ZOLADEX.
28
Reports of Malignant neoplasm progression with ZOLADEX
18.3%
of all ZOLADEX reports
4
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ZOLADEX?
Of the 28 reports, 4 (14.3%) resulted in death, 2 (7.1%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZOLADEX. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does ZOLADEX Cause?
Death (55)
Hot flush (17)
Interstitial lung disease (9)
Fatigue (6)
Therapy cessation (6)
Asthenia (5)
Breast cancer female (5)
Dizziness (5)
Off label use (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ZOLADEX Alternatives Have Lower Malignant neoplasm progression Risk?
ZOLADEX vs ZOLBETUXIMAB
ZOLADEX vs ZOLBETUXIMAB-CLZB
ZOLADEX vs ZOLEDRONIC ACID
ZOLADEX vs ZOLMITRIPTAN
ZOLADEX vs ZOLOFT